Powered by Bioz
CD32A/Fcgr2a, C-terminal Avi-HIS-tag, in vivo biotinylated
$326.43 – $1,171.80 excl. VAT
Soluble CD32A/Fcgr2a, C-terminally HIS-Avi-tagged, produced in HEK293 cells and in vivo mono-biotinylated. This product can be applied in multiplex assays to characterise IgG subclass-specific affinities supporting research into immune therapies, including therapeutic antibodies and novel vaccines.
CD32A/Fcgr2a, C-terminal Avi-HIS-tag, in vivo biotinylated
Soluble CD32A/Fcgr2a, C-terminally HIS-Avi-tagged, produced in HEK293 cells and in vivo mono-biotinylated. This product can be applied in multiplex assays to characterise IgG subclass-specific affinities supporting research into immune therapies, including therapeutic antibodies and novel vaccines.
PRODUCT DETAILS – CD32A/Fcgr2a
- Recombinant human C-terminally HIS-Avi-tagged, produced in HEK293 cells and in vivo mono-biotinylated.
- NCBI Accession: P12318-1
- Proteins were co-expressed in HEK293 cells and purified from culture supernatant by immobilised metal affinity chromatography.
- Presented as Liquid
Contact us for more details: nac.contact@lgcgroup.com
Useful links
- Junker, F., Gordon, J. and Qureshi, O. (2020) “FC gamma receptors and their role in antigen uptake, presentation, and T cell activation,” Frontiers in Immunology, 11. Available at: https://doi.org/10.3389/fimmu.2020.01393.
- Nath, N. et al. (2022) “A homogeneous bioluminescent immunoassay for parallel characterization of binding between a panel of antibodies and a family of Fcγ receptors,” Scientific Reports, 12(1). Available at: https://doi.org/10.1038/s41598-022-15887-z.